Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Demographic Data Supporting FDA Authorization of AI Devices for Alzheimer Disease and Related Dementias
0
Zitationen
6
Autoren
2025
Jahr
Abstract
This cohort study examines the availability and representativeness of data supporting US Food and Drug Administration–authorized artificial intelligence and machine learning devices to treat Alzheimer disease and related dementias.
Ähnliche Arbeiten
Explainable Artificial Intelligence (XAI): Concepts, taxonomies, opportunities and challenges toward responsible AI
2019 · 8.339 Zit.
Stop explaining black box machine learning models for high stakes decisions and use interpretable models instead
2019 · 8.211 Zit.
High-performance medicine: the convergence of human and artificial intelligence
2018 · 7.614 Zit.
Proceedings of the 19th International Joint Conference on Artificial Intelligence
2005 · 5.776 Zit.
Peeking Inside the Black-Box: A Survey on Explainable Artificial Intelligence (XAI)
2018 · 5.478 Zit.